# Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery

> **NCT06826742** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 30 (actual)

## Conditions studied

- Cesarean Delivery

## Interventions

- **DRUG:** Intravenous line (IV) Methadone
- **DRUG:** Intrathecal Morphine

## Key facts

- **NCT ID:** NCT06826742
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-12
- **Primary completion:** 2025-09-14
- **Final completion:** 2025-09-23
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06826742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06826742, "Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06826742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*